Vitamin Deficiency in Immigrants, a Treatment Study

• Status: Completed
• Trial end date: 2012-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the efficacy of different doses of vitamin D in persons, immigrated to Sweden from Middle East or Africa, with decreased S vitamin D.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Umeå University
• Treatments: Cholecalciferol; Ergocalciferols; Pharmaceutical Solutions; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Serum- vitamin D below 75 nmol/L

• Men and female

• 25-65 years of age

• Born in Middle East or Africa, living in Umeå district

Exclusion Criteria:

• Hypersensitive to Cholecalciferol, cocos oil, palm kernel or rubber

• Serum D3 equal to or above75 nmol/L

• Hypercalcemia

• Renal insufficiency

• History of Kidney Calculi

• Nephrocalcinosis

• History of sarcoidosis and other Granulomatous Diseases

• Known malignancy

• Ongoing treatment with phenytoin, barbiturates, rifampicin, isoniazid

• Ongoing treatment with cardiac glycosides

• Ongoing treatment with thiazides

• Ongoing treatment with Etalpha, Rocaltrol, ergocalciferol, Dygratal

• Ongoing treatment with drugs involving fat absorption; Orlistat Colestyramin

• Oral treatment with glucocorticoids

• Ongoing treatment with Aluminum Compounds drugs

• Ongoing treatment with Omega -3, vitamin D and/or calcium

• Immobilisation

• Other medial reason not to participate according to the investigator

• Pregnancy (women with S-D3 below 25 nmol/)

• Breastfeeding